Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Engineered skin tissue is a promising tool for safer cosmetic testing.

Extracellular vesicles can both worsen and help treat age-related diseases and are useful for early diagnosis.

Cosmetic microneedles are promising for precise treatments but face challenges like skin damage and regulations.

Frontal fibrosing alopecia in Bogotá mainly affects postmenopausal women, with possible links to hormonal changes and sunscreen use.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Aesthetic rehabilitation techniques can improve life quality and wellbeing for disabled patients.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Improper use of benzyl benzoate on a dog can cause severe skin reactions.

Tinea capitis in adults, especially postmenopausal Black women, needs prompt treatment with oral antifungals to avoid scarring.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

New technologies replicate human skin for testing without animals.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Herbal anti-dandruff shampoos can be as effective as synthetic ones, with fewer side effects.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.